Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease

Current Topics in Medicinal Chemistry

Volumn 16, Issue 14, 2016, Pages 1610-1630

  Santini, Giuseppe ^a   Mores, Nadia ^a   Penas, Andreu ^b   Capuano, Rosamaria ^c   Mondino, Chiara ^d   Trové, Andrea ^e   Macagno, Francesco ^a   Zini, Gina ^a   Cattani, Paola ^a   Martinelli, Eugenio ^c   Motta, Andrea ^f   Macis, Giuseppe ^a   Ciabattoni, Giovanni ^a   Montuschi, Paolo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Hospital   (Switzerland)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f CNR   (Italy)

Author keywords

Asthma; Biomarkers; Breathomics; Chemical sensors; Chronic obstructive pulmonary disease; Electronic nose; Exhaled breath condensate; Lung cancer; Metabolomics; NMR spectroscopy; Pattern recognition; Respiratory medicine; Volatile organic compounds

Indexed keywords

8 ISOPROSTANE; GLUTATHIONE; METALLOPORPHYRIN; N,N DIMETHYLACETAMIDE; PHENYLALANINE; POLITEF; POLYETHYLENE TEREPHTHALATE; PROSTAGLANDIN E2; SORBENT; VOLATILE ORGANIC COMPOUND;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; CYSTIC FIBROSIS; ELECTRONIC NOSE; EXHALED BREATH CONDENSATE; EXPIRATORY FLOW; EXPIRED AIR; HUMAN; LUNG CANCER; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PNEUMONIA; PULMONARY HYPERTENSION; QUARTZ CRYSTAL MICROBALANCE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; SINUSITIS; SLEEP DISORDERED BREATHING; SOLID PHASE MICROEXTRACTION; SUPPORT VECTOR MACHINE; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; WATER VAPOR; LUNG DISEASES; METABOLISM; PROCEDURES; PULMONOLOGY;

ELECTRONIC NOSE; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; PULMONARY MEDICINE;

EID: 84964285330     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026616666151223113540     Document Type: Article

References (137)

1. [1] Wheelock, C.E.; Goss, V.M.; Balgoma, D.; Nicholas, B.; Brandsma, J.; Skipp, P.J.; Snowden, S.; Burg, D.; D'Amico, A.; Horvath, I.; Chaiboonchoe, A.; Ahmed, H.; Ballereau, S.; Rossios, C.; Chung, K.F.; Montuschi, P.; Fowler, S.J.; Adcock, I.M.; Postle, A.D.; Dahlén, S.E.; Rowe, A.; Sterk, P.J.; Auffray, C.; Djukanovic, R.; U-BIOPRED Study Group. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur. Respir. J., 2013, 42, 802-825.
2. [2] Phillips, M. Method for the collection and assay of volatile organic compounds in breath. Anal. Biochem., 1997, 247, 272-278.
3. [3] Phillips, M.; Herrera, J.; Krishnan, S.; Zain, M.; Greenberg, J.; Cataneo, R.N. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B Biomed. Sci. Appl., 1999, 729, 75-88.
4. [4] Montuschi, P.; Mores, N.; Trové, A.; Mondino, C.; Barnes, P.J. The electronic nose in respiratory medicine. Respiration, 2013, 85, 72-84.
5. [5] Röck, F.; Barsan, N.; Weimar, U. Electronic nose: current status and future trends. Chem. Rev., 2008, 108, 705-711.
6. [6] Turner, A.; Magan, N. Electronic noses and disease diagnostic. Nat. Rev. Microbiol., 2004, 2, 161-166.
7. [7] Montuschi, P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther. Adv. Respir. Dis., 2007, 1, 5-23.
8. [8] Montuschi, P. Indirect monitoring of lung inflammation. Nat. Rev. Drug Discov., 2002, 1, 238-242.
9. [9] Motta, A.; Paris, D.; Melck, D.; de Laurentiis, G.; Maniscalco, M.; Sofia, M.; Montuschi P. Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur. Respir. J., 2012, 39, 498-500.
10. [10] Montuschi, P.; Paris, D.; Melck, D.; Lucidi, V.; Ciabattoni, G.; Raia, V.; Calabrese, C.; Bush, A.; Barnes, P.J.; Motta, A. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax, 2012, 67, 222-228.
11. [11] de Laurentiis, G.; Paris, D.; Melck, D.; Montuschi, P.; Maniscalco, M.; Bianco, A.; Sofia, M.; Motta, A. Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. J. Proteome Res., 2013, 12, 1502-1511.
12. [12] Montuschi, P.; Paris, D.; Montella, S.; Melck, D.; Mirra, V.; Santini, G.; Mores, N.; Montemitro, E.; Majo, F.; Lucidi, V.; Bush, A.; Motta, A.; Santamaria, F. Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis. Am. J. Respir. Crit. Care Med., 2014, 190, 229-233.
13. [13] Carraro, S.; Giordano, G.; Pirillo, P.; Maretti, M.; Reniero, F.; Cogo, P.E.; Perilongo, G.; Stocchero, M.; Baraldi, E. Airway metabolic anomalies in adolescents with bronchopulmonary dysplasia: new insights from the metabolomic approach. J. Pediatr., 2015, 166, 234-239.
14. [14] Baldwin, E.A.; Bai, J.; Plotto, A.; Dea, S. Electronic noses and tongues: applications for the food and pharmaceutical industries. Sensors (Basel), 2011, 11, 4744-4766.
15. [15] Deisingh, A.K.; Stone, D.C.; Thompson, M. Applications of electronic noses and tongues in food analysis. Int. J. Food Sci. Technol., 2004, 39, 587-604.
16. [16] Montuschi, P.; Santonico, M.; Mondino, C.; Pennazza, G.; Mantini, G.; Martinelli, E.; Capuano, R.; Ciabattoni, G.; Paolesse, R.; Di Natale, C.; Barnes, P.J.; D'Amico, A. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide and lung function testing in asthma. Chest, 2010, 137, 790-796.
17. [17] Fens, N.; Zwinderman, A.H.; van der Schee, M.P.; de Nijs, S.B.; Dijkers, E.; Roldaan, A.C.; Cheung, D.; Bel, E.H.; Sterk, P.J. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am. J. Respir. Crit. Care Med., 2009, 180, 1076-1082.
18. [18] Machado, R.; Laskowski, D.; Deffenderfer, O.; Burch, T.; Zheng, S.; Mazzone, P.; Mekhail, T.; Jennings, C.; Stoller, J.; Pyle, J.; Duncan, J.; Dweik, R.; Erzurum, S. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med., 2005, 171, 1286-1291.
19. [19] D'Amico, A.; Pennazza, G.; Santonico, M.; Martinelli, E.; Roscioni, C.; Galluccio, G.; Paolesse, R.; Di Natale, C. An investigation on electronic nose diagnosis of lung cancer. Lung Cancer, 2010, 68, 170-176.
20. [20] Thaler, E.R.; Lee, D.D.; Hanson, C.W. Diagnosis of rhinosinusitis with a colorimetric sensor array. J. Breath Res., 2008, 2:037016.
21. [21] Hockstein, N.G.; Thaler, E.R.; Torigian, D.; Miller, W.T.; Deffenderfer, O.; Hanson, C.W. Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings. Laryngoscope, 2004, 114, 1701-1705.
22. [22] Dragonieri, S.; Schot, R.; Mertens, B.J.; Le Cessie, S.; Gauw, S.A.; Spanevello, A.; Resta, O.; Willard, N.P.; Vink, T.J.; Rabe, K.F.; Bel, E.H.; Sterk, P.J. An electronic nose in the discrimination of patients with asthma and controls. J. Allergy Clin. Immunol., 2007, 120, 856-862.
23. [23] Dragonieri, S.; Annema, J.T.; Schot, R.; van der Schee, M.P.; Spanevello, A.; Carratú, P.; Resta, O.; Rabe, K.F.; Sterk, P.J. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer, 2009, 64, 166-170.
24. [24] Mazzone, P.J.; Hammel, J.; Dweik, R.; Na, J.; Czich, C.; Laskowski, D.; Mekhail, T. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax, 2007, 62, 565-568.
25. [25] Di Natale, C.; Macagnano, A.; Martinelli, E.; Paolesse, R.; D'Arcangelo, G.; Roscioni, C.; Finazzi-Agrò, A.; D'Amico, A. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens. Bioelectron., 2003, 18, 1209-1218.
26. [26] Hakim, M.; Billan, S.; Tisch, U.; Peng, G.; Dvrokind, I.; Marom, O.; Abdah-Bortnyak, R.; Kuten, A.; Haick, H. Diagnosis of headand-neck cancer from exhaled breath. Brit. J. Cancer, 2011, 104, 1649-1655.
27. [27] Fens, N.; Roldaan, A.C.; van der Schee, M.P.; Boksem, R.J.; Zwinderman, A.H.; Bel, E.H.; Sterk, P.J. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin. Exp. Allergy, 2011, 41, 1371-1378.
28. [28] Beckonert, O.; Keun, H.C.; Ebbels, T.M.; Bundy, J.; Holmes, E.; Lindon, J.C.; Nicholson, J.K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc., 2007, 2, 2692-2703.
29. [29] Nicholson, J.K.; Holmes, E.; Kinross, J.M.; Darzi, A.W.; Takats, Z.; Lindon, J.C. Metabolic phenotyping in clinical and surgical environments. Nature, 2012, 491, 384-392.
30. [30] Sofia, M.; Maniscalco, M.; de Laurentiis, G.; Paris, D.; Melck, D.; Motta, A. Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate. J. Biomed. Biotechnol., 2011, 2011:403260.
31. [31] Ibrahim, B.; Marsden, P.; Smith, J.A.; Custovic, A.; Nilsson, M.; Fowler, S.J. Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma. Allergy, 2013, 68, 1050-1056.
32. [32] Motta, A.; Paris, D.; D'Amato, M.; Melck, D.; Calabrese, C.; Vitale, C.; Stanziola, A.A.; Corso, G.; Sofia, M.; Maniscalco, M. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J. Proteome Res., 2014, 13, 6107-6120.
33. [33] Sinha, A.; Krishnan, V.; Sethi, T.; Roy, S.; Ghosh, B.; Lodha, R.; Kabra, S.; Agrawal, A. Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma. Eur. Respir. J., 2012, 39, 500-502.
34. [34] Carraro, S.; Rezzi, S.; Reniero, F.; Héberger, K.; Giordano, G.; Zanconato, S.; Guillou, C.; Baraldi, E. Metabolomics applied to exhaled breath condensate in childhood asthma. Am. J. Respir. Crit. Care Med., 2007, 175, 986-990.
35. [35] De Laurentiis, G.; Paris, D.; Melck, D.; Maniscalco, M.; Marsico, S.; Corso, G.; Motta, A.; Sofia, M. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur. Respir. J., 2008, 32, 1175-1183.
36. Amann, A.; Costello Bde, L.; Miekisch, W.; Schubert, J.; Buszewski, B.; Pleil, J.; Ratcliffe, N.; Risby, T. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J. Breath Res., 2014, 8(3):034001
37. de Lacy Costello, B.; Amann, A.; Al-Kateb, H.; Flynn, C.; Filipiak, W.; Khalid, T.; Osborne, D.; Ratcliffe, N.M. A review of the volatiles from the healthy human body. J. Breath Res., 2014, 8(1):014001.
38. Amann, A.; Mochalski, P.; Ruzsanyi, V.; Broza, Y.Y.; Haick, H. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. J. Breath. Res., 2014, 8(1):016003
39. [39] King, J.; Koc, H.; Unterkofler, K.; Mochalski, P.; Kupferthaler, A.; Teschl, G.; Teschl, S.; Hinterhuber, H.; Amann, A. Physiological modeling of isoprene dynamics in exhaled breath. J. Theor. Biol., 2010, 267, 626-637.
40. Koc, H.; King, J.; Teschl, G.; Unterkofler, K.; Teschl, S.; Mochalski, P.; Hinterhuber, H.; Amann, A. The role of mathematical modeling in VOC analysis using isoprene as a prototypic example. J. Breath Res., 2011, 5(3):037102.
41. Unterkofler, K.; King, J.; Mochalski, P.; Jandacka, M.; Koc, H.; Teschl, S.; Amann, A.; Teschl, G. Modeling-based determination of physiological parameters of systemic VOCs by breath gas analysis: a pilot study. J. Breath Res., 2015, 9(3):036002.
42. [42] Schleiss, M.B.; Holz, O.; Behnke, M.; Richter, K.; Magnussen, H.; Jörres, R.A. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur. Respir. J., 2000, 16, 1115-1118.
43. [43] Carpenter, C.T.; Price, P.V.; Christman, B.W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest, 1998, 114, 1653-1659.
44. [44] Montuschi, P.; Varone, F.; Valente, S.; Spina, D.; Mondino, C.; Ciappi G; Ciabattoni, G. Methodological aspects of exhaled prostanoid measurements. Eur. Respir. J., 2003, 22(Suppl. 45), 18s.
45. [45] Corradi, M.; Folesani, G.; Andreoli, R.; Manini, P.; Bodini, A.; Piacentini, G.; Carraro, S.; Zanconato, S.; Baraldi, E. Aldehydes and glutathione in exhaled breath condensate of children withasthma exacerbation. Am. J. Respir. Crit. Care Med., 2003, 167, 395-399.
46. [46] Corradi, M.; Rubinstein, I.; Andreoli, R.; Manini, P.; Caglieri, A.; Poli, D.; Alinovi, R.; Mutti, A. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2003, 167, 1380-1386.
47. [47] Hunt, J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J. Allergy Clin. Immunol., 2002, 110, 28-34.
48. Moritz, F.; Janicka, M.; Zygler, A.; Forcisi, S.; Kot-Wasik, A.; Kot, J.; Gebefügi, I.; Namiesnik, J.; Schmitt-Kopplin, P. The compositional space of exhaled breath condensate and its link to the human breath volatilome. J. Breath Res., 2015, 9(2):027105.
49. [49] Buck, L.; Axel, R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell, 1991, 65, 175-187.
50. [50] Bushdid, C.; Magnasco, M.O.; Vosshall, L.B.; Keller, A. Humans can discriminate more than 1 trillion olfactory stimuli. Science, 2014, 343, 1370-1372.
51. [51] D’Amico, A.; Di Natale, C.; Paolesse, R.; Macagnano, A.; Martinelli, E.; Pennazza, G.; Santonico, M.; Bernabei, M.; Roscioni, C.; Galluccio, G.; Bono, R.; Finazzi-Agrò, E.; Rullo, S. Olfactory systems for medical applications. Sensor and Actuators B, 2008, 130, 458-465.
52. [52] Miekisch, W.; Schubert, J.K;, Noeldge Schomburg, G.F. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin. Chim. Acta, 2004, 347, 25-39.
53. [53] Gromski, P.S.; Correa, E.; Vaughan, A.A.; Wedge, D.C.; Turner, M.L.; Goodacre, R. A comparison of different chemometrics approaches for the robust classification of electronic nose data. Anal. Bioanal. Chem., 2014, 406, 7581-7590.
54. [54] Wilson, A.D. Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath. Metabolites, 2015, 5, 140-163.
55. [55] Askim, J.R.; Mahmoudi, M.; Suslick, K.S. Optical sensor arrays for chemical sensing: the optoelectronic nose. Chem. Soc. Rev., 2013, 42, 8649-8682.
56. [56] Sethi, S.; Nanda, R.; Chakraborty, T. Clinical application of volatile organic compound analysis for detecting infectious diseases. Clin. Microbiol. Rev., 2013, 26, 462-475.
57. [57] Miekisch, W.; Kischkel, S.; Sawacki, A.; Liebau, T.; Mieth, M.; Schubert, J.K. Impact of sampling procedures on the results of breath analysis. J. Breath Res., 2008, 2:026007.
58. [58] Steeghs, M.M.; Cristescu, S.M.; Harren, F.J. The suitability of Tedlar bags for breath sampling in medical diagnostic research. Physiol. Meas., 2007, 28, 73-84.
59. [59] Bikov, A.; Pako, J.; Kovacs, D.; Tamasi, L.; Lazar, Z.; Rigo, J.; Losonczy, G.; Horvath, I. Exhaled breath volatile alterations in pregnancy assessed with electronic nose. Biomarkers, 2011, 16, 476-484.
60. [60] McNerney, R.; Mallard, K.; Okolo, P.I.; Turner, C. Production of volatile organic compounds by mycobacteria. FEMS Microbiol. Lett., 2012, 328, 150-156.
61. US Environment Protection Agency: Sampling of principal organic hazardous constituents from combustion sources using Tedlar bags. Method 0040. December 1996. Available at http://www.epa.gov /osw/hazard/testmethods/sw846/pdfs/0040.pdf.
62. [62] Koziel, J.A.; Spinhirne, J.P.; Lloyd, J.D.; Parker, D.B.; Wright, D.W.; Kuhrt, F.W. Evaluation of sample recovery of malodorous livestock gases from air sampling bags, solid-phase microextraction fibers, Tenax TA sorbent tubes, and sampling canisters. J. Air Waste Manag. Assoc., 2005, 55, 1147-1157.
63. [63] Kim, Y.H.; Kim, K.H.; Jo, S.H.; Jeon, E.C.; Sohn, J.R.; Parker, D.B. Comparison of storage stability of odorous VOCs in polyester aluminum and polyvinyl fluoride Tedlar® bags. Anal. Chim. Acta, 2012, 712, 162-167.
64. [64] Helmig, D.; Vierling, L. Water adsorption capacity of the solid adsorbents Tenax TA, Tenax GR, Carbotrap, Carbotrap C, Carbosieve III, and Carboxen 569 and water management techniques for the atmospheric sampling of volatile organic trace gases. Anal. Chem., 1995, 67, 4380-4386.
65. [65] Kwak, J.; Fan, M.; Harshman, S.W.; Garrison, C.E.; Dershem, V.L.; Phillips, J.B.; Grigsby, C.C.; Ott, D.K. Evaluation of Bio-VOC sampler for analysis of volatile organic compounds in exhaled breath. Metabolites, 2014, 4, 879-888.
66. [66] Röck, F.; Gurlo, A.; Weimar, U. Multisensor system for characterization of packaging emissions: prediction of total solvent amount and odor scores. Anal. Chem., 2005, 77, 2762-2769.
67. [67] Feng, L.; Musto, C.J.; Kemling, J.W.; Lim, S.H.; Zhong, W.; Suslick, K.S. Colorimetric sensor array for determination and identification of toxic industrial chemicals. Anal. Chem., 2010, 82, 9433-9440.
68. [68] Mochalski, P.; Wzorek, B.; Sliwka, I.; Amann, A. Suitability of different polymer bags for storage of volatile sulphur compounds relevant to breath analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877, 189-196.
69. [69] Keshri, G.; Magan, N.; Voysey, P. Use of an electronic nose for the early detection and differentiation between spoilage fungi. Lett. Appl. Microbiol., 1998, 27, 261-264.
70. [70] Kamboures, M.A.; Blake, D.R.; Cooper, D.M.; Newcomb, R.L.; Barker, M.; Larson, J.K.; Meinardi, S.; Nussbaum, E.; Rowland, F.S. Breath sulfides and pulmonary function in cystic fibrosis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877, 189-196.
71. [71] Woolfenden, E. Sorbent-based sampling methods for volatile and semi-volatile organic compounds in air Part 1: Sorbent-based air monitoring options. J. Chromatogr. A., 2010, 1217, 2674-2684.
72. [72] Woolfenden, E. Sorbent-based sampling methods for volatile and semi-volatile organic compounds in air. Part 2. Sorbent selection and other aspects of optimizing air monitoring methods. J. Chromatogr. A., 2010, 1217, 2685-2694.
73. [73] King, J.; Mochalski, P.; Kupferthaler, A.; Unterkofler, K.; Koc, H.; Filipiak, W.; Teschl, S.; Hinterhuber, H.; Amann, A. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol. Meas., 2010, 31, 1169-1184.
74. [74] Humphreys, L.; Orme, R.M.; Moore, P.; Charaklias, N.; Sahgal, N.; Pont, N.P.; Magan, N.; Stone, N.; Kendall, C.A. Electronic nose analysis of bronchoalveolar lavage fluid. Eur. J. Clin. Invest., 2011, 41, 52-58.
75. [75] Kolk, A.; Hoelscher, M.; Maboko, L.; Jung, J.; Kuijper, S.; Cauchi, M.; Bessant, C.; van Beers, S.; Dutta R.; Gibson, T.; Reither, K. Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis. J. Clin. Microbiol., 2010, 48, 4235-4238.
76. [76] Haddad, R.; Carmel, L.; Sobel, N.; Harel, D. Predicting the receptive range of olfactory receptors. PLoS Comput. Biol., 2008, 4:e18.
77. [77] Haddad, R.; Medhanie, A.; Roth, Y.; Harel, D.; Sobel, N. Predicting odor pleasantness with an electronic nose. PLoS Comput. Biol., 2010, 6:e1000740.
78. [78] Kang, N.K.; Jun, T.S.; La, D.-D.; Oh, J.H.; Cho, Y.W.; Kim, Y.S. Evaluation of the limit-of-detection capability of carbon blackpolymer composite sensors for volatile breath biomarkers. Sensors and Actuators B, 2010, 147, 55-60.
79. [79] Santonico, M.; Pennazza, G.; Capuano, R.; Falconi, C.; Vink, T.J.; Knobel, H.H.; Van der Schee, M.P.; Sterk, P.J.; Montuschi, P.; D’Amico, A. Electronic noses calibration procedure in the context of a multicentre medical study. Sens. Actuators B, 2012, 173, 555-561.
80. [80] Lewis, NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc. Chem. Res., 2004, 37, 663-672.
81. [81] Di Natale, C.; Paolesse, R.; D’Amico, A. Metalloporphyrins based artificial olfactory receptors. Sensor Actuators B, 2007, 121, 238-246.
82. [82] Rakow, N.A.; Suslick, K.S. A colorimetric sensor array for odour visualization. Nature, 2000, 406, 710-713.
83. [83] Dweik, R.A.; Boggs, P.B.; Erzurum, S.C.; Irvin, C.G.; Leigh, M.W.; Lundberg, J.O.; Olin, A.C.; Plummer, A.L.; Taylor, D.R; American Thoracic Society Committee on interpretation of exhaled nitric oxide levels (FENO) for clinical applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med., 2011, 184, 602-615.
84. [84] Silkoff, P.E.; Carlson, M.; Bourke, T.; Katial, R.; Ogren, E.; Szefler, S.J. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J. Allergy Clin. Immunol., 2004, 114, 1241-1256.
85. [85] Menzies, D.; Nair, A.; Lipworth, B.J. Portable exhaled nitric oxide measurement: comparison with the "gold standard" technique. Chest, 2007, 131, 410-414.
86. [86] Lindon, J.C.; Holmes, E.; Nicholson, J.K. Pattern recognition methods and applications in biomedical magnetic resonance. Progr. Nucl. Magn. Reson. Spectros., 2001, 39, 1-40.
87. [87] Leo, M.; Distante, C.; Bernabei, M.; Persaud, K. An efficient approach for preprocessing data from a large-scale chemical sensor array. Sensors (Basel), 2014, 14, 17786-17806.
88. [88] Scott, S.M.; James, D.; Ali, Z. Data analysis for electronic nose systems. Microchim. Acta, 2007, 156, 183-207.
89. [89] De Maesschalck, R.; Jouan-Rimbaud, D.; Massart, D.L. The Mahalanobis distance. Chemom. Intell. Lab. Syst., 2000, 50, 1-18.
90. [90] Bishop, C.M. Pattern Recognition and Machine Learning; Springer: Heidelberg, 2006.
91. Bofan, M.; Mores, N.; Baron, M.; Dabrowska, M.; Valente, S.; Schmid, M.; Trové, A.; Conforto, S.; Zini, G.; Cattani, P.; Fuso, L.; Mautone, A.; Mondino, C.; Pagliari, G.; D'Alessio, T.; Montuschi, P. Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD. J. Breath Res., 2013, 7(1):017103.
92. [92] Fens, N.; de Nijs, S.B.; Peters, S.; Dekker, T.; Knobel, H.H.; Vink, T.J.; Willard, N.P.; Zwinderman, A.H.; Krouwels, F.H.; Janssen, H.G.; Lutter, R.; Sterk, P.J. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur. Respir. J., 2011, 38, 1301-1309.
93. [93] Barker, M.; Hengst, M.; Schmid, J.; Buers, H.J.; Mittermaier, B.; Klemp, D.; Koppmann, R. Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur. Respir. J., 2006, 27, 929-936.
94. [94] Enderby, B.; Smith, D.; Carroll, W.; Lenney, W. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr. Pulmonol., 2009, 44, 142-147.
95. [95] Robroeks, C.M.; van Berkel, J.J.; Dallinga, J.W.; Jöbsis, Q.; Zimmermann, L.J.; Hendriks, H.J.; Wouters, M.F.; van der Grinten, C.P.; van de Kant, K.D.; van Schooten, F.J.; Dompeling, E. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr. Res., 2010, 68, 75-80.
96. Joensen, O.; Paff, T.; Haarman, E.G.; Skovgaard, I.M.; Jensen, P.Ø.; Bjarnsholt, T.; Nielsen, K.G. Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections. PLoS One, 2014, 9(12):e115584.
97. [97] Vogelmeier, C.F.; Köhler, U.; Koczulla, A.R. Detection of obstructive sleep apnoea by an electronic nose. Eur. Respir. J., 2013, 42, 145-155.
98. National Asthma Education and Prevention Program: Expert panel report III. Guidelines for the diagnosis and management of asthma. MD, Bethesda: National Heart, Lung, and Blood Institute, 2007; 1-61 (NIH publication no. 08-5847). Available at: www.nhlbi.nih.gov(accessed March 29, 2015)
99. [99] van der Schee, M.P.; Palmay, R.; Cowan, J.O.; Taylor, D.R. Predicting steroid responsiveness in patients with asthma using exhaled breath profiling. Clin. Exp. Allergy, 2013, 43, 1217-1225.
100. [100] Fens, N.; van der Sluijs, K.F.; van de Pol, M.A.; Dijkhuis, A.; Smids, B.S.; van der Zee, J.S.; Lutter, R.; Zwinderman, A.H.; Sterk, P.J.; RESOLVE Research Team. Electronic nose identifies bronchoalveolar lavage fluid eosinophils in asthma. Am. J. Respir. Crit. Care Med., 2015, 191, 1086-1088.
101. [101] Montuschi, P.; Malerba, M.; Santini, G.; Miravitlles, M. Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping. Drug Discov. Today, 2014, 19, 1928-1935.
102. [102] Sibila, O.; Garcia-Bellmunt, L.; Giner, J.; Merino, J.L.; Suarez-Cuartin, G.; Torrego, A.; Solanes, I.; Castillo, D.; Valera, J.L.; Cosio, B.G.; Plaza, V.; Agusti, A. Identification of airway bacterial colonization by an electronic nose in chronic obstructive pulmonary disease. Respir. Med., 2014, 108, 1608-1614.
103. [103] Bossuyt, P.M.; Reitsma, J.B.; Bruns, D.E.; Gatsonis, C.A.; Glasziou, P.P.; Irwig, L.M.; Moher, D.; Rennie, D.; de Vet, H.C.; Lijmer, J.G.; Standards for Reporting of Diagnostic Accuracy: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann. Intern. Med., 2003, 138, W1-12.
104. [104] Phillips, M.; Altorki, N.; Austin, J.H.; Cameron, R.B.; Cataneo, R.N.; Kloss, R.; Maxfield, R.A.; Munawar, M.I.; Pass, H.I.; Rashid, A.; Rom, W.N.; Schmitt, P.; Wai, J. Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin. Chim. Acta, 2008, 393, 76-84.
105. [105] Phillips, M.; Altorki, N.; Austin, J.H.; Cameron, R.B.; Cataneo, R.N.; Greenberg, J.; Kloss, R.; Maxfield, R.A.; Munawar, M.I.; Pass, H.I.; Rashid, A.; Rom, W.N.; Schmitt, P. Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark., 2007, 3, 95-109.
106. [106] Phillips, M.; Cataneo, R.N.; Cummin, A.R.; Gagliardi, A.J.; Gleeson, K.; Greenberg, J. Detection of lung cancer with volatile markers in the breath. Chest, 2003, 123, 2115-2123.
107. [107] Phillips, M.; Gleeson, K.; Hughes, J.M.; Greenberg, J.; Cataneo, R.N.; Baker, L.; McVay, W.P. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet, 1999, 353, 1930-1933.
108. [108] Gordon, S.M.; Szidon, J.P.; Krotoszynski, B.K.; Gibbons, R.D.; O'Neill, H.J. Volatile organic compounds in exhaled air from patients with lung cancer. Clin. Chem., 1985, 31, 1278-1282.
109. [109] Bruins, M.; Rahim, Z.; Bos, A.; van de Sande, W.W.; Endtz, H.P.; van Belkum, A. Diagnosis of active tuberculosis by e-nose analysis of exhaled air. Tuberculosis (Edinb), 2013, 93, 232-238.
110. [110] Pavlou, A.K.; Magan, N.; Jones, J.M.; Brown, J.; Klatser, P.; Turner, A.R. Detection of Mycobacterium tuberculosis (TB) in vitro and in situ using an electronic nose in combination with a neural network system. Biosens. Bioelectron., 2004, 20, 538-544.
111. [111] Fend, R.; Kolk, A.H.J.; Bessant, C.; Buijtels, P.; Klatser, P.R.; Woodman, A.C. Prospects for clinical application of electronicnose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J. Clin. Microbiol., 2006, 44, 2039-2045.
112. [112] Gibson, T.D.; Prosser, O.; Hulbert, J.N.; Marshall, R.W.; Corcoran, P.; Lowery, P.; Ruck-Keene, E.A.; Heron, S. Detection and simultaneous identification of microorganisms from headspace samples using an electronic nose. Sensors and Actuators B, 1997, 44, 413-422.
113. [113] Hockstein, N.G.; Thaler, E.R.; Lin, Y.Q.; Lee, D.D.; Hanson, C.W. Correlation of pneumonia score with electronic nose signature: A prospective study. Ann. Otol. Rhinol. Laryngol., 2005, 114, 504-508.
114. [114] Hanson, C.W.; Thaler, E.R. Electronic nose prediction of a clinical pneumonia score: biosensors and microbes. Anesthesiology, 2005, 102, 63-68.
115. [115] Lai, S.Y.; Deffenderfer, O.F.; Hanson, W.; Phillips, M.P.; Thaler, E.R. Identification of upper respiratory bacterial pathogens with the electronic nose. Laryngoscope, 2002, 112, 975-979.
116. [116] Kramer, R.; Sauer-Heilborn, A.; Welte, T.; Guzman, C.A.; Höfle, M.G.; Abraham, W.R. A rapid method for breath analysis in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis., 2015, 34, 745-751.
117. [117] Cohen-Kaminsky, S.; Nakhleh, M.; Perros, F.; Montani, D.; Girerd, B.; Garcia, G.; Simonneau, G.; Haick, H.; Humbert, M. A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array. Am. J. Respir. Crit. Care Med., 2013, 188, 756-759.
118. [118] Greulich, T.; Hattesohl, A.; Grabisch, A.; Koepke, J.; Schmid, S.; Noeske, S.; Nell, C.; Wencker, M.; Jörres, R.A.; Vogelmeier, C.F.; Köhler, U.; Koczulla, A.R. Detection of obstructive sleep apnoea by an electronic nose. Eur. Respir. J., 2013, 42, 145-155.
119. [119] Thaler, E.R.; Hanson, C.W. Use of an electronic nose to diagnose bacterial sinusitis. Am. J. Rhinol., 2006, 20, 170-172.
120. [120] Thaler, E.R.; Huang, D.; Giebeig, L.; Palmer, J.; Lee, D.; Hanson, C.W.; Cohen, N. Use of an electronic nose for detection of biofilms. Am. J. Rhinol., 2008, 22, 29-33.
121. [121] Preti, G.; Thaler, E.; Hanson, C.W.; Troy, M.; Eades, J.; Gelperin, A. Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877, 2011-2018.
122. [122] Mohamed, E.I.; Bruno, E.; Linder, R.; Alessandrin, M.; Di Girolamo, A.; Poppl, S.J.; Puija, A.; De Lorenzo, A. A novel method for diagnosing chronic rhinosinusitis based on an electronic nose. An Otorrinolaringol. Ibero Am., 2003, 30, 447-457.
123. [123] Shykhon, M.E.; Morgan, D.W.; Dutta, R.; Hines, E.L.; Gardner, J.W. Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study. J. Laryngol. Otol., 2004, 118, 706-709.
124. [124] Rogosch, T.; Herrmann, N.; Maier, R.F.; Domann, E.; Hattesohl, A.; Koczulla, A.R.; Zemlin, M. Detection of bloodstream infectionsand prediction of bronchopulmonary dysplasia in preterm neonates with an electronic nose. J. Pediatr., 2014, 165, 622-624.
125. [125] Eriksson, L.; Antti, H.; Gottfries, J.; Holmes, E.; Johansson, E.; Lindgren, F.; Long, I.; Lundstedt, T.; Trygg, J.; Wold, S. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal. Bioanal. Chem., 2004, 380, 419-429.
126. [126] Montuschi, P.; Barnes, P.J.; Ciabattoni, G. Measurement of 8-isoprostane in exhaled breath condensate. Methods Mol. Biol., 2010, 594, 73-84.
127. [127] Montuschi, P.; Corradi, M.; Ciabattoni, G.; Nightingale, J.; Kharitonov, S.A.; Barnes, P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am. J. Respir. Crit. Care Med., 1999, 160, 216-220.
128. [128] De Benedetto, F.; Aceto, A.; Dragani, B.; Spacone, A.; Formisano, S.; Cocco, R.; Sanguinetti, C.M. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch. Chest Dis., 2000, 55, 185-188.
129. [129] van Beurden, W.J.; Harff, G.A.; Dekhuijzen, P.N.; van den Bosch, M.J.; Creemers, J.P.; Smeenk, F.W. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir. Med., 2002, 96, 197-203.
130. [130] Izquierdo-Garcia, J.L.; Peces-Barba, G.; Heili, S.; Diaz, R.; Want, E.; Ruiz-Cabello, J. Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Eur. Respir. J., 2011, 37, 468-470.
131. [131] Trischler, J.; Merkel, N.; Könitzer, S.; Müller, C.M.; Unverzagt, S.; Lex, C. Fractionated breath condensate sampling: H2O2 concentrations of the alveolar fraction may be related to asthma control in children. Respir. Res., 2012, Feb 14;13:14.
132. [132] Trischler, J.; Müller, C.M.; Könitzer, S.; Prell, E.; Korten, I.; Unverzagt, S.; Lex, C. Elevated exhaled leukotriene B₄ in the small airway compartment in children with asthma. Ann. Allergy Asthma Immunol., 2015, 114, 111-116.
133. [133] Gajdocsi, R.; Brindicci, C.; Barnes, P.J.; Kharitonov, S.A. The reproducibility and accuracy of online hydrogen peroxide bioassay and the decreasing effect of storage on H2O2 concentration. Eur. Respir. J., 2003, 22(Suppl. 45), 279s.
134. [134] Hunt, J.F.; Erwin, E.; Palmer, L.; Vaughan, J.; Malhotra, N.; Platts-Mills, T.A.; Gaston, B. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am. J. Respir. Crit. Care Med., 2002, 165, 101-107.
135. [135] Bertini, I.; Luchinat, C.; Miniati, M.; Monti, S.; Tenori, L. Phenotyping COPD by 1H-NMR metabolomics of exhaled breath condensate. Metabolomics, 2014, 10, 302-311.
136. [136] McShane, L.M.; Cavenagh, M.M.; Lively, T.G.; Eberhard, D.A.; Bigbee, W.L.; Williams, P.M.; Mesirov, J.P.; Polley, M.Y.; Kim, K.Y.; Tricoli, J.V.; Taylor, J.M.; Shuman, D.J.; Simon, R.M.; Doroshow, J.H.; Conley, B.A. Criteria for the use of omics-based predictors in clinical trials. Nature, 2013, 502, 317-320.
137. [137] Collins, G.S.; Reitsma, J.B.; Altman, D.G.; Moons, K.G. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD). Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD). Ann. Intern. Med., 2015, 162, 735-736